Lakefront Biotherapeutics (LKFT)
28.61
+0.34
(+1.20%)
USD |
NASDAQ |
Jun 10, 16:00
28.60
-0.01
(-0.03%)
After-Hours: 20:00
Lakefront Biotherapeutics Price : 28.61 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 10, 2026 | 28.22 | 29.06 | 28.20 | 28.61 | 291518.0 |
| Jun 09, 2026 | 28.01 | 28.34 | 27.91 | 28.27 | 192522.0 |
| Jun 08, 2026 | 28.00 | 28.35 | 27.81 | 27.83 | 214730.0 |
| Jun 05, 2026 | 28.11 | 28.42 | 27.88 | 28.02 | 138611.0 |
| Jun 04, 2026 | 27.50 | 28.19 | 27.50 | 28.11 | 148929.0 |
| Jun 03, 2026 | 26.92 | 27.51 | 26.92 | 27.51 | 404665.0 |
| Jun 02, 2026 | 27.18 | 27.69 | 26.96 | 27.27 | 303524.0 |
| Jun 01, 2026 | 28.00 | 28.01 | 27.48 | 27.54 | 214498.0 |
| May 29, 2026 | 28.25 | 28.69 | 28.18 | 28.35 | 117842.0 |
| May 28, 2026 | 27.68 | 28.42 | 27.57 | 28.32 | 93242.00 |
| May 27, 2026 | 27.70 | 28.25 | 27.67 | 27.73 | 156226.0 |
| May 26, 2026 | 27.57 | 27.74 | 27.24 | 27.67 | 69614.00 |
| May 22, 2026 | 27.70 | 27.99 | 27.44 | 27.49 | 123617.0 |
| May 21, 2026 | 27.13 | 27.88 | 27.09 | 27.77 | 193847.0 |
| May 20, 2026 | 26.59 | 27.41 | 26.59 | 27.40 | 146250.0 |
| May 19, 2026 | 26.60 | 26.74 | 26.42 | 26.61 | 177426.0 |
| May 18, 2026 | 26.88 | 26.95 | 26.42 | 26.69 | 212558.0 |
| May 15, 2026 | 27.49 | 27.49 | 27.02 | 27.05 | 152082.0 |
| May 14, 2026 | 28.03 | 28.03 | 27.40 | 27.49 | 130546.0 |
| May 13, 2026 | 27.32 | 28.32 | 27.18 | 28.14 | 378586.0 |
| May 12, 2026 | 27.35 | 27.45 | 27.17 | 27.33 | 106961.0 |
| May 11, 2026 | 28.00 | 28.18 | 27.37 | 27.45 | 194448.0 |
| May 08, 2026 | 29.35 | 29.70 | 27.68 | 28.59 | 88692.00 |
| May 07, 2026 | 28.53 | 28.53 | 27.15 | 27.73 | 288095.0 |
| May 06, 2026 | 28.75 | 28.97 | 28.61 | 28.81 | 91758.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 121.48 |
| Karyopharm Therapeutics, Inc. | 9.11 |
| Ocugen, Inc. | 1.19 |
| Nkarta, Inc. | 2.46 |
| Zenas BioPharma, Inc. | 17.91 |
Price Related Metrics
| PE Ratio | 3.305 |
| PS Ratio | 1.572 |
| Price to Book Value | 0.5029 |
| Earnings Yield | 30.26% |
| Market Cap | 1.885B |
| Operating PE Ratio | 2.868 |
| Normalized PE Ratio | 2.490 |